America’s fisheries are among the world’s richest in abundance and diversity. They provide scientific, aesthetic, recreational, commercial, subsistence, cultural, social, and economic benefits. FAC leads aquatic resource management for the Service and strives to invest its resources in the nation’s highest priority aquatic conservation and water-based recreational needs. Fish health is a critical component of healthy fisheries and core to the work of the Fish and Aquatic Conservation Program.
The Aquatic Animal Drug Approval Partnership (AADAP) program is part of the Fish and Aquatic Conservation fish health work. It is the only program in the United States singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new medications needed for use in fish culture and fisheries management. Since the late 1990’s, AADAP has contributed to virtually every new fish medication approved by the FDA. Ultimately, the AADAP program allows fisheries professionals to more effectively and efficiently rear and manage a variety of fish species to meet production goals, stock healthy fish, and maintain a healthy environment.
Information to inform decisions regarding which medication to use, and how to use it. Safe, effective medications for treating fish diseases and managing fisheries—as well as informing the professionals who administer these medications—are growing needs.More
Investigational New Animal Drugs (INADs) are available through the National INAD Program (NIP) and can be used as long as study parameters are met and work is being done to reach full drug approval.More
Researchers use sound science to evaluate the safety and effectiveness of experimental fish medications. Results support FDA approval of the medications.More
Looking for an excuse to visit Bozeman, MT in 2019? Then it may be time to start making travel plans to attend the 25th Annual U.S. Fish and Wildlife Service, Aquaculture Drug Approval Coordination Workshop on July 29th-August 1st, 2019. A block of rooms are reserved at the Best Western GranTree Inn, at the rate of $157 per night. There is a limited number of rooms which will be released on June 29th, so make your reservations early, and be sure to mention one of the codes below to ensure you pay the special rate. Hotel information can be found below. Please use the Ticketbud link provided below to register for the meeting. In addition, please email Guppy Blair if you are interested in presenting at the workshop. An official call for abstracts and registration details will be sent out later this spring.
AADAP, the Association of Fish and Wildlife’s Drug Approval Working Group (AFWA/DAWG), and the National Aquaculture Association (NAA) conducted a nation-wide survey to assess the current and future unmet fish drug needs of hatchery personnel, fish health professionals, and fisheries management biologists across the U.S. The survey was meant to determine fish drug needs related to: 1) freshwater diseases/pathogens of concern to fisheries professionals, 2) non-therapeutic freshwater purposes (spawning, marking, sedation, etc.), and 3) culture and/or management of marine fish species in seawater environments. The survey was sent to federal, state, and private members of the aquaculture community over the time frame of summer 2017 - fall 2018.